Literature DB >> 15772917

Pathogenesis of parathyroid hyperplasia in renal failure.

Mario Cozzolino1, Diego Brancaccio, Maurizio Gallieni, Andrea Galassi, Eduardo Slatopolsky, Adriana Dusso.   

Abstract

In chronic kidney disease, secondary hyperparathyroidism (HPTH) is characterized by parathyroid hyperplasia and enhanced synthesis and secretion of parathyroid hormone (PTH). Elevated PTH levels cause renal osteodistrophy and cardiovascular complications, with significantly increased morbidity and mortality in renal failure. The three main direct causes of renal HPTH are hypocalcemia, hyperphosphatemia and vitamin D deficiency. A link between the mechanisms controlling proliferation and hormonal production also exists in normal parathyroid cells which respond to the stimulus of chronic hypocalcemia, not only by an increase in PTH release but also with a consequent parathyroid cell proliferation. The mechanisms responsible for this link, however, remain poorly understood. In this review, we analyze the current understanding concerning the new insights into the molecular mechanisms of parathyroid hyperplasia and PTH secretion in renal failure regulated by calcium, phosphate and vitamin D.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772917

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  12 in total

1.  Serum vitamin D and parathyroid hormone profiles in patients with various stages of renal disease.

Authors:  Abdelgayoum A Abdel-Gayoum
Journal:  Australas Med J       Date:  2015-02-28

2.  Timing of Parathyroidectomy Does Not Influence Renal Function After Kidney Transplantation.

Authors:  Willemijn Y van der Plas; Mostafa El Moumni; Philipp J von Forstner; Ezra Y Koh; Roderick R Dulfer; Tessa M van Ginhoven; Joris I Rotmans; Natasha M Appelman-Dijkstra; Abbey Schepers; Ewout J Hoorn; John Th M Plukker; Liffert Vogt; Anton F Engelsman; Els J M Nieveen van Dijkum; Schelto Kruijff; Robert A Pol; Martin H de Borst
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

Review 3.  Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease.

Authors:  Mario Cozzolino; Maurizio Gallieni; Sabina Pasho; Giuditta Fallabrino; Paola Ciceri; Elisa Maria Volpi; Laura Olivi; Diego Brancaccio
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Pin1 regulates parathyroid hormone mRNA stability.

Authors:  Rajiv Kumar
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

5.  Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure.

Authors:  Ely M Sebastian; Larry J Suva; Peter A Friedman
Journal:  Bone       Date:  2008-08-09       Impact factor: 4.398

6.  Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.

Authors:  Gerald Miller; James Davis; Edward Shatzen; Matthew Colloton; David Martin; Charles M Henley
Journal:  Nephrol Dial Transplant       Date:  2011-10-29       Impact factor: 5.992

7.  Successful use of low-dose intravenous paricalcitol in the treatment of severe secondary hyperparathyroidism in a haemodialysis patient.

Authors:  Mario Cozzolino; Andrea Galassi; Maurizio Gallieni; Diego Brancaccio
Journal:  NDT Plus       Date:  2008-03-01

Review 8.  Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.

Authors:  Joao F de Brito Galvao; Larry A Nagode; Patricia A Schenck; Dennis J Chew
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2013 Mar-Apr

9.  Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Li Fang; Bing Tang; Dawei Hou; Meijuan Meng; Mingxia Xiong; Junwei Yang
Journal:  BMC Nephrol       Date:  2015-06-10       Impact factor: 2.388

10.  Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.

Authors:  Willemijn Y van der Plas; Anton F Engelsman; Akin Özyilmaz; Anouk N van der Horst-Schrivers; Kornelis Meijer; Gooitzen M van Dam; Robert A Pol; Martin H de Borst; Schelto Kruijff
Journal:  Ann Surg Oncol       Date:  2016-07-26       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.